Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9DML

Human muscle nAChR with fab2-bound

This is a non-PDB format compatible entry.
Summary for 9DML
Entry DOI10.2210/pdb9dml/pdb
EMDB information47009
DescriptorFab2 heavy chain, (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate, CHOLESTEROL, ... (11 entities in total)
Functional Keywordshuman muscle, nicotinic acetylcholine receptor, membrane protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains9
Total formula weight392273.32
Authors
Li, H.,Hibbs, R.E. (deposition date: 2024-09-13, release date: 2025-04-09, Last modification date: 2025-10-22)
Primary citationLi, H.,Pham, M.C.,Teng, J.,O'Connor, K.C.,Noviello, C.M.,Hibbs, R.E.
Autoimmune mechanisms elucidated through muscle acetylcholine receptor structures.
Cell, 188:2390-2406.e20, 2025
Cited by
PubMed Abstract: Skeletal muscle contraction is triggered by acetylcholine (ACh) binding to its ionotropic receptors (AChRs) at neuromuscular junctions. In myasthenia gravis (MG), autoantibodies target AChRs, disrupting neurotransmission and causing muscle weakness. While treatments exist, variable patient responses suggest pathogenic heterogeneity. Progress in understanding the molecular basis of MG has been limited by the absence of structures of intact human muscle AChRs. Here, we present high-resolution cryoelectron microscopy (cryo-EM) structures of the human adult AChR in different functional states. Using six MG patient-derived monoclonal antibodies, we mapped distinct epitopes involved in diverse pathogenic mechanisms, including receptor blockade, internalization, and complement activation. Electrophysiological and binding assays revealed how these autoantibodies directly inhibit AChR channel activation. These findings provide critical insights into MG immunopathogenesis, uncovering unrecognized antibody epitope diversity and modes of receptor inhibition, and provide a framework for developing personalized therapies targeting antibody-mediated autoimmune disorders.
PubMed: 40203823
DOI: 10.1016/j.cell.2025.03.004
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.24 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon